Esperion Therapeutics Stockholders Approve Merger Agreement

At a special meeting held on July 8, 2026, stockholders of Esperion Therapeutics, Inc. (ESPR) voted to adopt the Agreement and Plan of Merger, dated May 1, 2026, with Essence Parent Inc. and Essence MergerCo Inc. This development was reported in a Form 8-K filing with the SEC.